Jean-Luc Balzer email address & phone number | Miso Chip Chief Executive Officer contact information - RocketReach
![Atoll, Atoll, Alain Gozzo, Michel Taillet, John Wetton, Romain Didier, Alain Gozzo, Andre Balzer, Michel Taillet, John Wetton, Christian Beya, Jean Luc Thillot - Rock Puzzle - Amazon.com Music Atoll, Atoll, Alain Gozzo, Michel Taillet, John Wetton, Romain Didier, Alain Gozzo, Andre Balzer, Michel Taillet, John Wetton, Christian Beya, Jean Luc Thillot - Rock Puzzle - Amazon.com Music](https://m.media-amazon.com/images/W/IMAGERENDERING_521856-T1/images/I/51fMn5uRIPL._UF350,350_QL80_.jpg)
Atoll, Atoll, Alain Gozzo, Michel Taillet, John Wetton, Romain Didier, Alain Gozzo, Andre Balzer, Michel Taillet, John Wetton, Christian Beya, Jean Luc Thillot - Rock Puzzle - Amazon.com Music
![Nicolas VODOVAR | Senior Associate Researcher - Group Leader Cardiovascular Endocrinology (CARE) | PhD | French Institute of Health and Medical Research | Inserm | UMR-S 942 | Research profile Nicolas VODOVAR | Senior Associate Researcher - Group Leader Cardiovascular Endocrinology (CARE) | PhD | French Institute of Health and Medical Research | Inserm | UMR-S 942 | Research profile](https://i1.rgstatic.net/ii/profile.image/1164663278575620-1654688772683_Q512/Nicolas-Vodovar.jpg)
Nicolas VODOVAR | Senior Associate Researcher - Group Leader Cardiovascular Endocrinology (CARE) | PhD | French Institute of Health and Medical Research | Inserm | UMR-S 942 | Research profile
![Behind the Deal: MISO Chip. The story behind FRV's investment in… | by Gabriel Dannenbaum | Front Row Ventures Blog Behind the Deal: MISO Chip. The story behind FRV's investment in… | by Gabriel Dannenbaum | Front Row Ventures Blog](https://miro.medium.com/v2/resize:fit:1400/1*p5yKEWImQ6baZQ4zfFUA8g.jpeg)
Behind the Deal: MISO Chip. The story behind FRV's investment in… | by Gabriel Dannenbaum | Front Row Ventures Blog
![Behind the Deal: MISO Chip. The story behind FRV's investment in… | by Gabriel Dannenbaum | Front Row Ventures Blog Behind the Deal: MISO Chip. The story behind FRV's investment in… | by Gabriel Dannenbaum | Front Row Ventures Blog](https://miro.medium.com/v2/resize:fit:1400/1*z4RCf8xsUIGiBAaxMUpFXQ.png)
Behind the Deal: MISO Chip. The story behind FRV's investment in… | by Gabriel Dannenbaum | Front Row Ventures Blog
![OxyNov, Desjardins-Innovatech and CTS Santé join forces to revolutionize the treatment of chronic obstructive pulmonary disease, the world's fifth leading cause of death with 3 million fatalities per year OxyNov, Desjardins-Innovatech and CTS Santé join forces to revolutionize the treatment of chronic obstructive pulmonary disease, the world's fifth leading cause of death with 3 million fatalities per year](https://mma.prnewswire.com/media/510921/Desjardins_Innovatech_OxyNov__Desjardins_Innovatech_and_CTS_Sant.jpg?p=facebook)